Association of a mutation in the ryanodine receptor 1 gene with equine malignant hyperthermia
- 27 July 2004
- journal article
- research article
- Published by Wiley in Muscle & Nerve
- Vol. 30 (3) , 356-365
- https://doi.org/10.1002/mus.20084
Abstract
Equine malignant hyperthermia (MH) has been suspected but never genetically confirmed. In this study, we investigated whether mutations in a candidate gene, RyR1, were associated with MH in two clinically affected horses. RyR1 gene sequences revealed polymorphisms in exons 15, 17, and 46 in WTRyR1 and MHRyR1 horses with one derived amino acid change in MHRyR1 exon 46, R2454G. The MHRyR1 horses were genetically heterozygous for this mutation, but presented an MH phenotype with halothane challenge. Skeletal sarcoplasmic reticulum from a R2454G heterozygote collected during a fulminant MH episode showed significantly higher affinity and density of [3H]ryanodine‐binding sites compared to WTRyR1, but no differences in Ca2+, Mg2+, and caffeine modulation. In conclusion, an autosomal missense mutation in RyR1 is associated with MH in the horse, providing a screening test for susceptible individuals. [3H]ryanodine‐binding analysis suggests that long‐lasting changes in RyR1 conformation persists in vitro after the triggering event. Muscle Nerve 30: 356–365, 2004Keywords
This publication has 35 references indexed in Scilit:
- Increased sensitivity of the ryanodine receptor to halothane-induced oligomerization in malignant hyperthermia-susceptible human skeletal muscleJournal of Applied Physiology, 2004
- A new mutation in the skeletal ryanodine receptor gene (RYR1) is potentially causative of malignant hyperthermia, central core disease, and severe skeletal malformationAmerican Journal of Medical Genetics Part A, 2003
- Suspected malignant hyperthermia in a horse anaesthetized with halothaneVeterinary Anaesthesia and Analgesia, 2002
- Genotype-phenotype comparison of the Swiss malignant hyperthermia populationHuman Mutation, 2001
- Screening of the ryanodine receptor gene in 105 malignant hyperthermia families: novel mutations and concordance with the in vitro contracture testHuman Molecular Genetics, 1999
- Reduced inhibitory effect of Mg2+ on ryanodine receptor-Ca2+ release channels in malignant hyperthermiaBiophysical Journal, 1997
- Malignant-Hyperthermia Susceptibility Is Associated with a Mutation of the a1-Subunit of the Human Dihydropyridine-Sensitive L-Type Voltage-Dependent Calcium-Channel Receptor in Skeletal MuscleAmerican Journal of Human Genetics, 1997
- Postanesthetic Equine Myopathy Suggestive of Malignant Hyperthermia: A Case ReportVeterinary Surgery, 1990
- Localization of the malignant hyperthermia susceptibility locus to human chromosome 19ql2–13.2Nature, 1990